Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Henry N. Ginsberg et al.|European Heart Journal|2017Cited by 3.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, Chris J. Packard et al.|European Heart Journal|2020Cited by 1.5k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyOlov Wiklund, Éric Bruckert, Robert A. Hegele et al.|European Heart Journal|2014Cited by 1.1k
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Olov Wiklund, Samuel S. Gidding et al.|European Heart Journal|2015Cited by 868
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G. Nordestgaard, Michel R. Langlois, Anne Langsted et al.|European Heart Journal|2016Cited by 830